FDA
-
-
-
-
-
-
-
Clearmind gets clearance to advance AUD drug trial to patient cohorts
-
-
-
-
-
-
-
Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
-
-
-
-
-
-
-
Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
-
-
-
-
-
-
-
Clearmind Medicine responds to Trump executive order on psychedelic drugs
-
-
-
-
-
-
-
Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
-
-
-
-
-
-
Clearmind Medicine advances to next phase of alcohol disorder trial
-
-
-
-
-
-
-
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
-
330,122 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

